Concepedia

Chaitra S. Ujjani

CS

Statistics

Publications

63

Citations

3.5K

H-Index

26

Active since

2009

Affiliations

Fred Hutch Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

University of Washington

University of Pennsylvania

Columbia University Irving Medical Center

Chaitra S. Ujjani is an author at Fred Hutch Cancer Center specializing in medicine, oncology, and immunotherapy.

ORCID

Publications per year

2009–2025

63

Publications

63

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis

Anthony R. Mato, Chadhi Nabhan, Meghan C. Thompson et al. · Haematologica · 2018 · 452 citations · Full text

, , +12

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Anthony R. Mato, Lindsey E. Roeker, Nicole Lamanna et al. · Blood · 2020 · 318 citations · Full text

, , +3

Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial

Sattva S. Neelapu, Michael Dickinson, Javier Muñoz et al. · Nature Medicine · 2022 · 283 citations · Full text

, , +17

Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients

Anthony R. Mato, Brian T. Hill, Nicole Lamanna et al. · Annals of Oncology · 2017 · 224 citations · Full text

, , +16

Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia

Anthony R. Mato, Jennifer A. Woyach, Jennifer R. Brown et al. · New England Journal of Medicine · 2023 · 217 citations · Full text

, , +15

1–5 of 63